Comprehensive Online Oncology Database
New Medicine Oncology KnowledgeBASE
NEWS
SUBSCRIBER SEARCH
(Requires Login)
NEW DRUG
MARKETED DRUG
COMPANY
TARGETS IN ONCOLOGY
NEWS AND WEBCAST SUMMARIES
COMBINATION TRIALS
  
   1-949-830-0448   info@newmedinc.com   
 
ABOUT nm|OK
nm|OK FREE ACCESS AND DEMO
APPLICATIONS
DESCRIPTION OF MODULES
INQUIRIES AND FEEDBACK
LICENSE AGREEMENT
PRIVACY POLICY
SAMPLE QUERY SCREENS
SAMPLE REPORTS & RECORDS
SOURCES
SUBSCRIPTION INFORMATION
USER GUIDE

PRODUCTS AND SERVICES
FUTURE ONCOLOGY
FEATURED IN-DEPTH REPORTS
CUSTOM REPORT REQUEST

NEWS
NEWS SUMMARIES
LATEST nm|OK UPDATES
nm|OK NEWS RELEASES

SITE MAP
Having trouble finding something?
Use our site map.
 

Latest Updates
June 2008 New Drug Updates and Additions

Brand Name
Generic Name
Other Designation
  Granisetron APF530
    ABT-869, ABT869
ProLindac   AP5346
    AEG35156/GEM640
Alpharadin    
    PCK3145
TVT-Dox Doxorubicin  
  Goserelin  
  Octreotide C2L
    AMG-655, AMG 655
Xanafide Amonafide L-malate NSC 308847
NeuVax   E75
    ABS212
    AG-003, AGS-003
    AGS-005
Cerepro   EG009
    ARQ-650RP, ARQ 650RP, ARQ 197, ARQ197
    ARRY-380, ARRY-333786
    AT-101
    AT7519, AT-7519
    AT9283
    AT13387
    AT13148
MVA-BN PRO    
  Telatinib BAY 57-9352
BEMA-fentanyl Fentanyl  
    Anti-PIGF, TB-403
Imprime PGG, Imprime WPG    
    BIBF 1120
    BIBW 2992
    BI 2536
Neuradiab   131I-c81C6
  Brivanib alalinate BMS-582664
    GVAX prostate cancer vaccine
Ceflatonin Omacetaxine mepesuccinate CGX-635, NSC-141633
    CHR-2797, CHR2797
Elacyt Ara-C, cytarabine CP-4055
  Salirasib  
CCS technology    
Aurimmune   CYT-6091
AuriTol, AuriTax   CYT-21001
AuriCin   CYT-31000
CYT-41000    
CYT-51000    
    ISS-1018, 1018 ISS
    E7820, NSC 719239
Rexonum Ertumaxomab  
  Obatoclax mesylate GX15-070 • GX015-070 • GX015-070MS
Omnitarg Pertuzumab R1273, 2C4, rhuMAb-2C4
HhAntag   Cur-691, GDC-0449
  Dacetuzumab SGN-40, SGN40 (anti-huCD40 MAb), huS2C6
TNFerade    
Promacta Eltrombopag SB 497115, SB-497115, SB497115
Tarmogen   GI-4000, GI-4014, GI-4015 and GI-4016
  Romidepsin FR901228, FK228, NSC630176
Orplatna Satraplatin JM-216 (formerly BMS-182751)
Marqibo (formerly Onco TCS), Vincristine Optisome Vincristine sulfate liposomes for injection (VSLI)  
  Chidamide HBI-8000, CS055
    INCB7839, INCB007839
    INCB18424
    INSM-18
    BN2629, BN-2629, SP-2001, SJG-136, SJG136, NCI 694501, SG 2000
    JX-594
    KXO1 • KX01 • KX2-391
    UCN-01, KW-2401, KRX-0601; NSC 638850
    KW-2449
    LX1032
    GTI 2040, GTI-2040
    MDVN 300 series, MDV3100
    MK-2461
IMOxine   HYB2055, IMO-2055
  Adecatumumab MT201, MT-201
  Blinatumomab MT103, MT-103, MEDI-538
    MT110
    bscEphA2xCD3
    MLN8054
Azedra, Ultratrace iobenguane I-131 Iobenguane I 131 MIP-120T, Ultratrace MIBG
    MORAb-028, MORAb28
    P276, P-276, P276-00
    NS-187, INNO-406, CNS-9
    DMXAA, AS1404, AS-1404, ASA404
    AT9311, NVP-LCQ195
Chemetics    
    OGX-427
Telomelysin   OBP-301
Reolysin (formerly Reosyn)    
    ON 01910.Na, ON01910.Na, ON01910
    PX-866, PX866
    OSI-930
    OSI-906
    SU014813, SU-14,813
    PF-299804, PF-00299804, PF-299,804
    PF-03814735
Xcytrin Motexafin gadolinium PCI-0120, GdT2B2, MGd
    CRA-024781, CG-781, PCI-24781
    PM02734
    POL6326
    PR-104
    RTA 402 (CDDO-Me)
    RP101, INOC001
    R1507, formerly Roche 1
    RO4584820, CDKi, R547
Zamyl Lintuzumab HuM195, SMART M195, SGN-33
    SGN-35, SGN35
    SGN-75, SGN75
Interceptors   SF1126
    eIF5A1, eIF-5A, factor 5A1, factor 5A
    SNX-5422, SNX5422
  Gimatecan ST-1481/ST-1480, LBQ707
  Voreloxin SNS-595, SPC-595 (formerly AG-7352)
    SNS-314
    MS-275, MS275, SNDX-275
    TAP1, AdhTAP
    D93, TRC093
  Methoxyamine TRC102
    TRC105, c-SN6j
    TG4010, MVA-MUC-1-IL-2, MVA-MUC1-IL-2
  Chlorotoxin 131-I-TM-601, 131-I-TM601, TM601
Veglin   VEGF-AS
Lenocta Sodium stibogluconate (SSG) VQD001, VQD-001
Xyfid Uracil  
    XmAb
    XmAb 2513


HOME   |   NEW MEDICINE   |   SITE MAP

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM